Parameter | Overall (n = 59) | Conduit (n = 49) | Orthotopic Neobladder (n = 10) | p value |
---|---|---|---|---|
Mean age (± SD), years | 53.35(12.8) | 52(12.2) | 62.8(12.04) | 0.125 |
Gender | ||||
Male | 52(88.1%) | 44(89.8%) | 8(80%) | 0.001 |
Female | 7(11.86%) | 5(10.2%) | 2(20) | |
Presentation | ||||
Hematuria | 56(94.9) | 47(95.9%) | 9(90%) | 0.673 |
Incidental | 3(5.08%) | 2(4.1%) | 1(10%) | |
Patients having obstructive uropathy at presentation | 23(38.98%) | 21(42.85%) | 2(20%) | 0.458 |
Patients undergoing preoperative percutaneous nephrostomy | 15(25.42%) | 14(23.72%) | 1(10%) | 0.501 |
ASA score, mean (± SD) | 1.9 (0.69) | 1.91(0.64) | 1.6(0.84) | 0.015 |
Co-morbidities | ||||
Hypertension | 25(42.3%) | 18(36.7%) | 6(60%) | 0.381 |
Diabetes | 18(30.50%) | 12(24.5%) | 5(50%) | 0.266 |
Hypothyroidism | 10(16.94%) | 5(10.2%) | 3(30%) | 0.015 |
Old H/O Coronary artery disease | 5(8.47%) | 2(4.1%) | 2(20%) | 0.062 |
COPD | 7(11.86%) | 4(8.2%) | 2(20%) | 0.260 |
Presence of hydronephrosis on CT | 30(50.84%) | 25(51.02%) | 5(50%) | 0.797 |
Dwelling | ||||
Rural | 51(86.44%) | 43(87.8%) | 5(50%) | 0.012 |
urban | 8(13.55%) | 6(12.2%) | 5(50%) | |
Smoking Status | ||||
Smokers | 48(81.35%) | 36(73.5%) | 10(100%) | 0.169 |
Non Smokers | 11(18.64%) | 13(26.5%) | 0(-) | |
Pesticide exposure | ||||
Yes | 36(61.01%) | 30(61.2%) | 3(30%) | 0.061 |
No | 23(38.9%) | 19(38.8%) | 7(70%) | |
Presence of significant pelvic lymphadenopathy on CT scan | 28(47.45%) | 24(48.97%) | 4(40%) | 0.132 |
Neo-adjuvant chemotherapy | 8(13.56%) | 8(16.3%) | 0(-) | 0.296 |